Cargando…

Tazarotene-Induced Gene 1 Enhanced Cervical Cell Autophagy through Transmembrane Protein 192

Tazarotene-induced gene 1 (TIG1) is a retinoic acid-inducible protein that is considered a putative tumor suppressor. The expression of TIG1 is decreased in malignant prostate carcinoma or poorly differentiated colorectal adenocarcinoma, but TIG1 is present in benign or well-differentiated tumors. E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shyu, Rong-Yaun, Wang, Chun-Hua, Wu, Chang-Chieh, Chen, Mao-Liang, Lee, Ming-Cheng, Wang, Lu-Kai, Jiang, Shun-Yuan, Tsai, Fu-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Molecular and Cellular Biology 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223105/ https://www.ncbi.nlm.nih.gov/pubmed/27989102 http://dx.doi.org/10.14348/molcells.2016.0161

Ejemplares similares

Tazarotene-Induced Gene 1 Interacts with DNAJC8 and Regulates Glycolysis in Cervical Cancer Cells
por: Wang, Chun-Hua, et al.
Publicado: (2018)

Tazarotene-induced gene 1 inhibits prostaglandin E2-stimulated HCT116 colon cancer cell growth
por: Tsai, Fu-Ming, et al.
Publicado: (2011)

G protein-coupled receptor kinase 5 mediates Tazarotene-induced gene 1-induced growth suppression of human colon cancer cells
por: Wu, Chang-Chieh, et al.
Publicado: (2011)

Tazarotene-Induced Gene 1 (TIG1) Interacts with Serine Protease Inhibitor Kazal-Type 2 (SPINK2) to Inhibit Cellular Invasion of Testicular Carcinoma Cells
por: Shyu, Rong-Yaun, et al.
Publicado: (2019)

Induction of apoptosis by the retinoid inducible growth regulator RIG1 depends on the NC motif in HtTA cervical cancer cells
por: Tsai, Fu-Ming, et al.
Publicado: (2009)

H-rev107 regulates prostaglandin D2 synthase-mediated suppression of cellular invasion in testicular cancer cells
por: Shyu, Rong-Yaun, et al.
Publicado: (2013)

Phospholipase A/Acyltransferase enzyme activity of H-rev107 inhibits the H-RAS signaling pathway
por: Wang, Chun-Hua, et al.
Publicado: (2014)

Tazarotene as alternative topical treatment for onychomycosis
por: Campione, Elena, et al.
Publicado: (2015)

A review of tazarotene in the treatment of photodamaged skin
por: Ogden, Stephanie, et al.
Publicado: (2008)

Use of tazarotene foam for the treatment of acne vulgaris
por: Gregoriou, Stamatis, et al.
Publicado: (2014)

Safety and efficacy of tazarotene foam for the treatment of acne vulgaris
por: Epstein, Erica L, et al.
Publicado: (2013)

A phase 1 study of tazarotene in adults with advanced cancer
por: Jones, P H, et al.
Publicado: (2003)

Successful treatment of median canaliform nail dystrophy with topical tazarotene foam
por: Quan, Eugenie Y., et al.
Publicado: (2022)

Tazarotene gel with narrow-band UVB phototherapy: a synergistic combination in psoriasis
por: Dayal, Surabhi, et al.
Publicado: (2018)

Photostability Testing of a Third-Generation Retinoid—Tazarotene in the Presence of UV Absorbers
por: Kryczyk-Poprawa, Agata, et al.
Publicado: (2020)

A Case of Pincer Nail Successfully Treated with Tazarotene 0.1% Gel
por: Vollono, Laura, et al.
Publicado: (2020)

Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency
por: Schlotawa, Lars, et al.
Publicado: (2023)

BOWENOID PAPULOSIS OF THE GENITALIA SUCCESSFULLY TREATED WITH TOPICAL TAZAROTENE: A REPORT OF TWO CASES
por: Shastry, Veeranna, et al.
Publicado: (2009)

Impact of Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045% in the Management of Plaque Psoriasis in Adults
por: Reddy, Vidhatha, et al.
Publicado: (2020)

Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits
por: Lebwohl, Mark G., et al.
Publicado: (2021)

Microsponge based gel as a simple and valuable strategy for formulating and releasing Tazarotene in a controlled manner
por: Khattab, Alaa, et al.
Publicado: (2022)

Tackling acne vulgaris by fabrication of tazarotene-loaded essential oil-based microemulsion: In vitro and in vivo evaluation
por: Badawi, Noha M., et al.
Publicado: (2023)

EVALUATION OF TOPICAL 0.1% TAZAROTENE CREAM IN THE TREATMENT OF PALMOPLANTAR PSORIASIS: AN OBSERVER-BLINDED RANDOMIZED CONTROLLED STUDY
por: Mehta, Bijal H, et al.
Publicado: (2011)

Tazarotene-Induced Gene 3 May Affect Inflammatory Angiogenesis in Psoriasis by Downregulating Placental Growth Factor Expression
por: Jeon, Su-Young, et al.
Publicado: (2014)

GelMA/PEGDA microneedles patch loaded with HUVECs-derived exosomes and Tazarotene promote diabetic wound healing
por: Yuan, Meng, et al.
Publicado: (2022)

Antipsychotic Drugs Inhibit Platelet Aggregation via P2Y(1) and P2Y(12) Receptors
por: Wu, Chang-Chieh, et al.
Publicado: (2016)

Comparative Analysis of 60Co and 192Ir Sources in High Dose Rate Brachytherapy for Cervical Cancer
por: Wen, Aiping, et al.
Publicado: (2022)

Transition rates in $^{192}$Au
por: Höglund, A, et al.
Publicado: (1971)

Transition rates in $ ^{192}Au$
por: Höglund, A, et al.
Publicado: (1971)

LIN92#19.2
Publicado: (1993)

Real-time simultaneous detection of microbial contamination and determination of an ultra low-content active pharmaceutical ingredient in tazarotene gel by near-infrared spectroscopy
por: Xie, Qian, et al.
Publicado: (2018)

Radiobiological and dosimetric comparison of 60Co versus 192Ir high-dose-rate intracavitary-interstitial brachytherapy for cervical cancer
por: Wen, Aiping, et al.
Publicado: (2022)

Quasiparticle excitations in superdeformed $^{192}$Hg
por: Fallon, P, et al.
Publicado: (1995)

Health Tract, No. 192: Mind and Body
Publicado: (1865)

Health Tract, No. 192: Mind and Body
Publicado: (1864)

Statistical Sequential Experimentation: Preliminary Mixed Factorial Design, I-Optimal Mixture Design Then Finally Novel Design Space Expansion for Optimization of Tazarotene Cubosomes
por: Hegazy, Doaa, et al.
Publicado: (2022)

TMBIM6 (transmembrane BAX inhibitor motif containing 6) enhances autophagy through regulation of lysosomal calcium
por: Kim, Hyun-Kyoung, et al.
Publicado: (2020)

Transmembrane protein 121 as a novel inhibitor of cervical cancer metastasis
por: Yang, Boyu, et al.
Publicado: (2022)

RacGAP1 promotes the malignant progression of cervical cancer by regulating AP-1 via miR-192 and p-JNK
por: Zhang, Tianli, et al.
Publicado: (2022)

Development and Validation of a Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Phenoxyethanol, Methylparaben, Propylparaben, Mometasone Furoate, and Tazarotene in Topical Pharmaceutical Dosage Formulation
por: Roy, Chinmoy, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ru0jfkon3vr8ks4n9adoghjecr